We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-3 of 3

Unhappy returns - the Astrazeneca case strikes again
  • Gowling WLG
  • United Kingdom
  • October 15 2010

The Office of Fair Trading (OFT) announced this morning that Reckitt Benckiser has agreed to pay a penalty of £10.2 million for an abuse of dominant position in the market for the NHS supply of alginate and antacid heartburn medicines.